144 related articles for article (PubMed ID: 31605722)
1. Doxorubicin combined with betulinic acid or lonidamine in RGD ligand-targeted pH-sensitive micellar system for ovarian cancer treatment.
Jin X; Zhou J; Zhang Z; Lv H
Int J Pharm; 2019 Nov; 571():118751. PubMed ID: 31605722
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery by pH-responsive mPEG-S-PBLG micelles significantly enhances the anti-tumor efficacy of doxorubicin with reduced cardiotoxicity.
Feng Q; Xu J; Liu X; Wang H; Xiong J; Xiao K
Drug Deliv; 2021 Dec; 28(1):2495-2509. PubMed ID: 34842005
[TBL] [Abstract][Full Text] [Related]
3. Dual-pH responsive micelle platform for co-delivery of axitinib and doxorubicin.
Xu X; Li L; Zhou Z; Sun W; Huang Y
Int J Pharm; 2016 Jun; 507(1-2):50-60. PubMed ID: 27154256
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable Micellar HPMA-Based Polymer-Drug Conjugates with Betulinic Acid for Passive Tumor Targeting.
Lomkova EA; Chytil P; Janoušková O; Mueller T; Lucas H; Filippov SK; Trhlíková O; Aleshunin PA; Skorik YA; Ulbrich K; Etrych T
Biomacromolecules; 2016 Nov; 17(11):3493-3507. PubMed ID: 27636143
[TBL] [Abstract][Full Text] [Related]
5. A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth.
Zhang D; Xu Q; Wang N; Yang Y; Liu J; Yu G; Yang X; Xu H; Wang H
Int J Nanomedicine; 2018; 13():4549-4561. PubMed ID: 30127606
[TBL] [Abstract][Full Text] [Related]
6. RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells.
He X; Alves CS; Oliveira N; Rodrigues J; Zhu J; Bányai I; Tomás H; Shi X
Colloids Surf B Biointerfaces; 2015 Jan; 125():82-9. PubMed ID: 25437067
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer.
Kim D; Gao ZG; Lee ES; Bae YH
Mol Pharm; 2009; 6(5):1353-62. PubMed ID: 19507896
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhetinic acid-conjugated polymeric prodrug micelles co-delivered with doxorubicin as combination therapy treatment for liver cancer.
Yang T; Lan Y; Cao M; Ma X; Cao A; Sun Y; Yang J; Li L; Liu Y
Colloids Surf B Biointerfaces; 2019 Mar; 175():106-115. PubMed ID: 30529816
[TBL] [Abstract][Full Text] [Related]
9. Micelle System Based on Molecular Economy Principle for Overcoming Multidrug Resistance and Inhibiting Metastasis.
Qi Y; Qin X; Yang C; Wu T; Qiao Q; Song Q; Zhang Z
Mol Pharm; 2018 Mar; 15(3):1005-1016. PubMed ID: 29397749
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive DNA nanomicelles for chemo-gene synergetic therapy of anaplastic large cell lymphoma.
Li Y; Yue S; Cao J; Zhu C; Wang Y; Hai X; Song W; Bi S
Theranostics; 2020; 10(18):8250-8263. PubMed ID: 32724469
[TBL] [Abstract][Full Text] [Related]
11. Bile Acid-Based Drug Delivery Systems for Enhanced Doxorubicin Encapsulation: Comparing Hydrophobic and Ionic Interactions in Drug Loading and Release.
Cunningham AJ; Robinson M; Banquy X; Leblond J; Zhu XX
Mol Pharm; 2018 Mar; 15(3):1266-1276. PubMed ID: 29378128
[TBL] [Abstract][Full Text] [Related]
12. Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells.
Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
Pharm Res; 2008 Nov; 25(11):2555-66. PubMed ID: 18636321
[TBL] [Abstract][Full Text] [Related]
13. PEG-oligocholic acid telodendrimer micelles for the targeted delivery of doxorubicin to B-cell lymphoma.
Xiao K; Luo J; Li Y; Lee JS; Fung G; Lam KS
J Control Release; 2011 Oct; 155(2):272-81. PubMed ID: 21787818
[TBL] [Abstract][Full Text] [Related]
14. Chemical Architecture of Block Copolymers Differentially Abrogate Cardiotoxicity and Maintain the Anticancer Efficacy of Doxorubicin.
Abdullah CS; Ray P; Alam S; Kale N; Aishwarya R; Morshed M; Dutta D; Hudziak C; Banerjee SK; Mallik S; Banerjee S; Bhuiyan MS; Quadir M
Mol Pharm; 2020 Dec; 17(12):4676-4690. PubMed ID: 33151075
[TBL] [Abstract][Full Text] [Related]
15.
Zhu LB; Xu WL; Zhang WW; Wu MC; Li WZ; Ge F; Tao YG; Song P
Nanotechnology; 2021 Apr; 32(29):. PubMed ID: 33711826
[TBL] [Abstract][Full Text] [Related]
16. pH/redox dual-responsive amphiphilic zwitterionic polymers with a precisely controlled structure as anti-cancer drug carriers.
Wu Z; Gan Z; Chen B; Chen F; Cao J; Luo X
Biomater Sci; 2019 Aug; 7(8):3190-3203. PubMed ID: 31145392
[TBL] [Abstract][Full Text] [Related]
17. All-Trans Retinoic Acid and Doxorubicin Delivery by Folic Acid Modified Polymeric Micelles for the Modulation of Pin1-Mediated DOX-Induced Breast Cancer Stemness and Metastasis.
Liu Y; Yu F; Dai S; Meng T; Zhu Y; Qiu G; Wen L; Zhou X; Yuan H; Hu F
Mol Pharm; 2021 Nov; 18(11):3966-3978. PubMed ID: 34579532
[TBL] [Abstract][Full Text] [Related]
18. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
